Inhibikase Therapeutics Inc (IKT): Biji pasar

The Inhibikase Therapeutics (IKT) price visualization on the GURU.Markets platform reflects the asset's dynamics, with a current value of 0.22. Anticipation regarding the results of Phase II trials for its Parkinson's disease treatment is fueling trader excitement. The business model relies on developing long-term medications protected by a robust patent shield, while therapy reliability is ensured through complex temperature-controlled logistics, which increases delivery costs.

IKT inhibikase.com: Kapitalisasi pasar ing interval 04.07.2022 - 22.10.2026

Rincian metrik lan analitis perusahaan Inhibikase Pharma (IKT)

Inhibikase Therapeutics (IKT): dhaptar indikator lan metrik:

Bagan rega Inhibikase Therapeutics, Inc.|IKT - Prakiraan konsensus analis|Biji pasar Inhibikase Pharma

Ringkesan analisis perusahaan:IKT (Inhibikase Therapeutics, Inc.)

Produk sing diprodhuksi Inhibikase Therapeutics

The biotech sector is often subject to sharp volatility due to regulatory risks, yet the independence of the Inhibikase Therapeutics (IKT) product cycle from macroeconomic factors creates a significant margin of safety. The company's market capitalization dynamics reflect the current market consensus regarding the value of all business shares. Analyzing this market capitalization allows for the identification of asset overvaluation and the precise calculation of an M&A premium, which protects investor capital from unjustified price spikes.

Analisis pesaing

Nilai pasar Biogen BIIB|Kapitalisasi pasar Neurocrine NBIX|RGC: Biji pasar|Axsome Corp - Nilai pasar|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Kapitalisasi pasar XENE|VKTX (Viking Therapeutics, Inc.) - Kapitalisasi pasar|Nilai pasar Supernus Pharmaceuticals, Inc. SUPN|Biji pasar CPRX (Catalyst Pharmaceuticals Inc)|Kapitalisasi pasar Denali Corp (DNLI)|Nilai pasar Harmony Biosciences HRMY|Nilai pasar BHVN|AMLX - Nilai pasar|Nilai pasar Trevi Therapeutics Inc|PRAX: Kapitalisasi pasar|AVXL - Kapitalisasi pasar|Nilai pasar CeriBell, Inc.|Kapitalisasi pasar PRTA (Prothena Corp)|Kapitalisasi pasar ALEC|ANNX (Annexon Biosciences) - Nilai pasar|Kapitalisasi pasar OMER (Omeros)|Kapitalisasi pasar Neurogene Therapeutics (NGNE)|AC Immune - Kapitalisasi pasar|VYGR: Nilai pasar|NMRA: Kapitalisasi pasar|SCLX - Kapitalisasi pasar|Nilai pasar Tevogen Bio Holdings, Inc.|Kapitalisasi pasar Alpha Cognition Corp|Kapitalisasi pasar CGTX|Kapitalisasi pasar cassavasciences.com (SAVA)|Nilai pasar Assertio ASRT|Kapitalisasi pasar Coya Therapeutics Inc (COYA)|VistaGen Therapeutics Inc - Kapitalisasi pasar|Nilai pasar Ovid Therapeutics Inc.|ABOS (Acumen Pharmaceuticals) - Biji pasar|cervomed.com - Nilai pasar|Biji pasar ATHE|CLNN (Clene Nanomedicine) - Nilai pasar|Kapitalisasi pasar PEPG|JUNS (jupiterneurosciences.com) - Nilai pasar|Kapitalisasi pasar RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Nilai pasar|GRCE - Nilai pasar|Nilai pasar AIFF (Firefly Neuroscience, Inc.)|KLTO: Kapitalisasi pasar|NeuroSense Therapeutics Ltd. (NRSN) - Kapitalisasi pasar|Nilai pasar Reviva Pharmaceuticals|MetaVia, Inc. - Biji pasar|Kapitalisasi pasar NRXS|HSDT - Nilai pasar|Passage Bio - Biji pasar|Kapitalisasi pasar Neuphoria Therapeutics, Inc. NEUP|NERV: Biji pasar|athira.com - Nilai pasar|ADXN: Kapitalisasi pasar|ALZN - Kapitalisasi pasar|CYCN (Cyclerion Therapeutics Inc.) - Kapitalisasi pasar|Biji pasar Protagenic (PTIX)|Nilai pasar Pasithea Therapeutics (KTTA)|Kapitalisasi pasar cortigent.com|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|Kapitalisasi pasar Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Nilai pasar|CHRO - Kapitalisasi pasar|ELYM (eliemtx.com) - Biji pasar|ITCI: Nilai pasar|Nilai pasar Longboard Pharmaceuticals, Inc.|Kapitalisasi pasar MRNS (Marinus Pharmaceuticals Inc)|Kapitalisasi pasar NKGN|NRBO - Nilai pasar|Sage Therapeutics, Inc. - Biji pasar|Kapitalisasi pasar synaptogen.com SNPX|TRVN - Nilai pasar|Nilai pasar VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Nilai pasar|Nilai pasar Cerevel Corp (CERE)